1 / 27

Upper Respiratory Tract Infections

Upper Respiratory Tract Infections. Mark S. Johnson, Pharm.D., BCPS Associate Professor and Director of Postgraduate Education. Respiratory Tract. Two sections Upper Respiratory Tract (URT) Most have viral etiology; Self-limiting and resolve on own Lower Respiratory Tract (LRT).

graham
Download Presentation

Upper Respiratory Tract Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Upper Respiratory Tract Infections Mark S. Johnson, Pharm.D., BCPS Associate Professor and Director of Postgraduate Education

  2. RespiratoryTract • Two sections • Upper Respiratory Tract (URT) • Most have viral etiology; • Self-limiting and resolve on own • Lower Respiratory Tract (LRT) http://dsa.csupomona.edu/shs/twc/images/respiratory_full.jpg

  3. Respiratory Tract Infections • Major cause of morbidity from acute illness in U.S. • Most common reason patients seek medical care • Accounts for majority of prescribed antibiotics • Most common cause for LRTI • Follow colonization of upper respiratory tract • Gain access by aspiration of oropharyngeal secretions • Usually during sleep • Other sources for LRTI infection • Extrapulmonary source through blood • Inhaled aersolized, infected particles

  4. Otitis media Rhinitis http://www.fluwikie.com/uploads/Science/resp.jpg

  5. Types of Infections • Upper Respiratory Tract Infections • Otitis media • Sinusitis • Epiglottitis • Pharyngitis • Laryngitis (croup) • Rhinitis

  6. Upper Respiratory Tract Components Sinuses Middle Ear Epiglottis http://www.nlm.nih.gov/medlineplus/ency/images/ency/fullsize/19378.jpg

  7. Otitis Media • Inflammation of the middle ear • Follows cold symptoms • Common occurrence: infants and children (esp. < 3 yr) • Otitis media with effusion • Acute infection is not present • Signs and symptoms • Otalgia (sometimes severe)* • Fever • Irritability, lethargy, anorexia, vomiting • Hearing loss • Presence of fluid in the middle ear • Tympanic membrane: discolored, bulging, thickened, and immobile

  8. Otitis Media Otoscopy and Tympanometry Otoscopy Grade 1 Grade 4 Grade 7 Tympanometry http://www.ems-ceu.com/courses/122/index_ems.html

  9. Otitis MediaRisk factors • Race • Aboriginal or Inuit Origin • Age • Early age of 1st diagnosis (esp. < 6 mo) • Family • Siblings at home • Genetic predisposition • Malformations • Gender • Environmental • Second-had smoke • Urban population • Lower socioeconomic status • Daycare attendance • Use of a pacifier • Winter season • Virus outbreak • Immunodeficiency • Allergy • Nasopharyngeal colonization with middle ear pathogens • Prior antibiotic exposure • Lack of breastfeeding

  10. Otitis MediaEtiology, Diagnosis, Resolution • Pathogenic Causes • Bacteria (most common): S. pneumoniae • Common: H. influenzae, M. catarrhalis • Less frequent: S. aureus, S. pyogenes, P. aeruginosa • Viruses • Lab Tests that can be used • Gram stain, culture and sensitivities of draining or aspirated fluid • Duration without treatment • Resolution in one week (pain and fever in 2-3 days)

  11. Otitis MediaTreatment • Goals • Reduce and control of symptoms (esp. pain) • Eradicate infection • Prevent complications (mastoiditis, bacteremia, meningitis, auditory problems) • Minimize adverse drug reactions (ADRs) • Avoid unnecessary antibiotic use

  12. Otitis MediaTreatment • Drug of choice (DOC): Amoxicillin (high dose, HD)* • Dose: 80-90 mg/kg/day • PCN allergy (non Type I): Beta-lactamase stable cephalosporin (cefuroxime, cefdinir, cefpodoxime) • Anaphylaxis (Type I): Macrolides (azithro-, clarithomycin) • Second-line (if failure on amox 48-72 hours after initiated) • DOC: HD amoxicillin-clavulanate • Dose: Amox 80-90 mg/kg/d + clavulanate 6.4 mg/kg/d in 2 divided doses • Others include beta lactamase stable cephaloporins as noted above • Ceftriaxone*50mg/kg/d IM/IV for 3 days • Clindamycin 30-40mg/kg/day if resistant Stept pneumo is documented • Duration of therapy: 10 days • Shorter course: 5-7 days (age > 6 yrs generally) *Achieve concentrations above MIC > 40% of dosing interval in middle ear fluids

  13. Otitis MediaTreatment • Adjunct therapy • Analgesics and antipyretics • Other • Tympanostomy tube (T-tube) placement • Adenoidectomy • Tympanocentesis • Propylaxis • Antibiotics: Controversial • Consider if 3 infections (6 mo) or 4 infections (12 mo) • Vaccines: Influenza and Pneumococcal

  14. Sinusitis • Inflammation of sinus mucosa • Types: Acute or chronic • Children (common); adults (less frequent) • Signs and symptoms • Acute • Adult • Mucopurulent nasal discharge, congestion • Maxillary tooth, sinus, or facial pain (unilateral) • Morning preorbital swelling • Halitosis • Children • Cough, nasal discharge (> 10-14 days) • Fever (> 39C), facial swelling, pain • Resolution without treatment • Acute: duration of 4 weeks; Chronic: duration of 12 weeks

  15. Acute SinusitisEtiology and Diagnosis • Pathogens • Primary: Viruses • Bacteria (most common): S. pneumoniae • Common: Haemophilus influenzae, Moroxella catarrhalis • Less frequently: S. pyogenes, S. aureus, anaerobes • Fungi • Other: Allergens • Diagnosis • Determination of causative organism • Viral: 7-10 days; Bacterial: >7-14 days • Transillumination of maxillary sinuses • X-ray, CT/MRI of sinuses • Sinus puncture, aspiration, and culture

  16. Acute Sinusitis Treatment • Goals • Reduce and improve symptoms • Improve and restore sinus function • Resolve bacterial infection • Minimize illness duration • Prevent complications • Prevent disease progression • Limit unnecessary antibiotics use

  17. Acute SinusitisTreatment • Mild disease • Nasal or oral decongestants • Expectorant • Saline and steam inhalation • Possibly intranasal steroids • Not antihistamines (unless possibly chronic sinusitis) • Moderate to severe disease (> 7 days) • Antimicrobial therapy • Referral to specialist • No response to 1st and 2nd line therapy • Recurrent and chronic disease • At risk for complications

  18. Acute SinusitisTreatment • DOC: Amoxicillin (500mg TID PO) • PCN allergy: beta-lactamase stable cephalosporin • Anaphylaxis: Macrolides or resp quinolone or doxycycline or TMP-SMX • High suspicion of drug-resistance (S. pnemo): HD amoxicillin (1gm TID PO) or Clindamycin • Alternative: resp quinolone • Treatment failure or recent prior antibiotic therapy in past 4-6 weeks • HD Amoxicillin-clavulanate (2gm/125mg BID PO) or beta-lactamase stable cephalosporin • Alternates: Resp quinolone • Duration of therapy: 10-14 days

  19. Chronic SinusitisClinical Presentation and Etiology • Signs and Symptoms • Similar to acute sinusitis • Inflammation lasting > 3 months • Rhinorrhea, headache • Chronic unproductive cough • Laryngitis • Recurrent or chronic infections (3-4 x’s per year) • Unresponsive to decongestants or steam • Pathogens • Bacteria • Common anaerobes: Prevotella, anerobic strep, fusobacterium • Aerobes: Strep, sp., Haemophilus, P. aeruginosa, S. aureus, M. catarrhalis • Fungi

  20. Chronic SinusitisTreatment • Antibiotics usually not effective for long-term treatment • Only use with an acute exacerbation • Supportive care • Otolarygology consult

  21. Epiglottitis • Inflammation of the epiglottis • Present commonly: ages 2-6 • Airway emergency • Rapid onset • No culture: Acute obstruction • Signs and symptoms • Stridor • Fever • 4 D’s: respiratory distress, drooling, dysphagia, dysphonia • Diagnosis • Neck X-ray or CT/MRI

  22. Epiglotitis Etiology and Treatment • Pathogenic Causes • Bacteria: Haemophilus influenzae type B (HIB) • Other: S. pneumoniae, S. aureus, Group A strep (adult) (S. pyogenes) • Treatment • Maintain airway • DOC: 2nd or 3rd generation cephalosporin (e.g., cefotaxime or ceftriaxone) • Alternate: Ampicillin-sulbactam or TMP-SMX • Other: Ertapenem, imipenem; respiratory quinolones (moxi- or levofloxacin); cefprozil • Corticosteroids • Other: Tracheostomy

  23. Pharyngitis • Acute inflammation of the naso- or oropharynx • All ages susceptible • Highest risk • Children (ages 5-15), Individuals who work with children, Parents of children • Signs and symptoms • Sudden onset of sore throat, fever, dysphagia • Headache, N/V, abdominal pain (children) • Tender, enlarged lymph nodes • Inflammation and erythema of uvula, pharynx and tonsils, possibly with exudates • Rash, petechiae • Resolution without treatment • 3-7 days; Few weeks: lymph nodes and tonsils

  24. PharyngitisEtiology • Pathogens • Primary: Viruses • Bacterial: group A beta-hemolytic Streptococcus (S. pyogenes), others • Fungal: Candida albicans • Other causes: Allergens • Diagnosis • Rapid antigen detection testing (RADT) • Results in 10 min – 1 hour • Positive test = antibiotic therapy • Traditional throat swab and culture if negative RADT in children, adolescents, parents, schoolteachers—24-48h for results

  25. PharyngitisTreatment • Goals • Improve symptoms • Minimize adverse drug reactions • Prevent transmission • Prevent complications • Cervical lymphadenitis • Mastoiditis • Peritonsillar abcess • Additional Complications • Acute rheumatic fever or reactive arthritis • Acute glumerulonephritis • Otitis media, sinusitis • Necrotizing fascitis

  26. PharyngitisTreatment • DOC: Penicillin VK (250mg TID or QID PO or 500mg BID PO) • Children: PCN VK (50mg/kg/d TID PO) or Amoxicillin (has better taste) 40-50mg/kg/d PO • NPO: Benzathine G PCN 1.2MU IM • PCN allergy: 1st gen cephalosporin (cephalexin 250mg-500mg QID PO) • Anaphylaxis: macrolide (erythro-, azithro-, clarithromycin) • Drug-resistance or failure • 2nd or 3rd gen oral cephalosporin with B-lactamase stability • 2nd gen: Cefuroxime, cefprozil • 3rd gen: Cefpodoxime, cefdinir • Documented macrolide resistance: clindamycin • Recurrent episodes • Amox-clav or clindamycin • Duration of therapy: 10 days

  27. Laryngitis (Croup) • Inflammation of the larynx • Common presence: age < 3 • Causes • Three types • Viral – parainfluenza virus, RSV • Spasmodic • Bacterial: S. aureus, Group A Strep (beta-hemolytic), HIB • Signs and symptoms • Hoarseness • Stridor, barking cough • Treatment • Antibiotics not indicated, unless bacterial etiology • Corticosteroids • Racemic epinephrine • Humidified oxygen

More Related